---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-021302"
form_type: "8-K"
ticker: "ATXI"
cik: "0001644963"
company_name: "AVENUE THERAPEUTICS, INC."
filed_at: "2024-06-26T23:59:59+00:00"
generated_at: "2026-06-01T01:34:21.757231+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Avenue Therapeutics stockholders approve 5M share increase to 2015 Incentive Plan

## Summary
- Stockholders approved amendment to 2015 Incentive Plan, increasing authorized shares by 5,000,000.
- Plan term extended to June 24, 2034; non-employee director annual limit increased to 500,000 shares.
- All six director nominees elected; KPMG ratified as auditor for FY2024.
- Total shares reserved under the plan after amendment: 5,070,223.

## SEC filing metadata
- accession: 0001437749-24-021302
- form_type: 8-K
- ticker: ATXI
- cik: 0001644963
- company_name: AVENUE THERAPEUTICS, INC.
- filed_at: 2024-06-26T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1644963/000143774924021302/0001437749-24-021302-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1644963/000143774924021302/atxi20240625_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-021302
- JSON: https://secwatch.observer/filing/0001437749-24-021302.json
- Plain text: https://secwatch.observer/filing/0001437749-24-021302.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.